Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
qianlie tongyu
- Development stage
- Unknown
- Lead developer
- Zhuhai Xingguang Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Qianlie Tongyu is a Chinese Patent Medicine (CPM) developed by Zhuhai Xingguang Pharmaceutical for the treatment of chronic non-bacterial prostatitis (Type IIIA). Formulated as an oral capsule, it is designed based on Traditional Chinese Medicine (TCM) principles to address syndromes characterized by blood stasis obstruction and internal accumulation of damp-heat. Clinical development has focused on evaluating the efficacy and safety of new versus original formulations in patients suffering from chronic pelvic pain syndrome (CPPS) associated with prostatitis. The drug aims to alleviate symptoms such as pelvic pain and urinary dysfunction by resolving stasis and clearing heat.
- Brand names
- Qianlie Tongyu Capsule
- Other names
- 前列通瘀胶囊Qianlie Tongyu Jiaonang
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on qianlie tongyu.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on qianlie tongyu.